Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY31.19 CNY
Change Today +1.81 / 6.16%
Volume 17.5M
As of 3:00 AM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

beijing beilu pharmaceutic-a (300016) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/2/15 - CNY66.58
52 Week Low
01/6/15 - CNY13.81
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BEIJING BEILU PHARMACEUTIC-A (300016)

Related News

No related news articles were found.

beijing beilu pharmaceutic-a (300016) Related Businessweek News

No Related Businessweek News Found

beijing beilu pharmaceutic-a (300016) Details

Beijing Beilu Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers oral contrast agents in magnetic resonance imaging (MRI) for abdominal check; Gadopentetate Dimeglumine injection for cranial and spinal MRI and whole body MRI; Iohexol injection for use in the blood vessels and body cavities of adults and children. The company also provides Glimepiride tablets for Type 2 diabetes mellitus, as well as an anti-anxiety product for the treatment of generalized anxiety disorder suffering from heart and spleen double deficiency syndrome. Beijing Beilu Pharmaceutical Co., Ltd. was founded in 1992 and is based in Beijing, the People’s Republic of China.

Founded in 1992

beijing beilu pharmaceutic-a (300016) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

beijing beilu pharmaceutic-a (300016) Key Developments

Beijing Beilu Pharmaceutical Co., Ltd. to Report First Half, 2015 Results on Aug 25, 2015

Beijing Beilu Pharmaceutical Co., Ltd. announced that they will report first half, 2015 results on Aug 25, 2015

Beijing Beilu Pharmaceutical Co., Ltd. Announces Implementation of Cash Dividend for the Year 2014, Payable on 25 May 2015

Beijing Beilu Pharmaceutical Co., Ltd. announced the implementation of cash dividend of CNY 0.60000000 per 10 shares (tax included) for the year 2014. Record date for the dividend is 22 May 2015, ex-date is 25 May 2015 and the payment date is 25 May 2015. Net cash dividend of CNY 0.54000000 per 10 shares after tax.

Beijing Beilu Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, May 22, 2015

Beijing Beilu Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, May 22, 2015., at 09:30 China Standard Time. Agenda: To consider by-election of directors; and to consider by-election of independent directors.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300016:CH CNY31.19 CNY +1.81

300016 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300016.
View Industry Companies

Industry Analysis


Industry Average

Valuation 300016 Industry Range
Price/Earnings 86.7x
Price/Sales 16.6x
Price/Book 13.1x
Price/Cash Flow 88.6x
TEV/Sales 16.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BEIJING BEILU PHARMACEUTIC-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at